Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia

NCT07099443 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT07099443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07099443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determinants of the Response to BTK Degraders (BTKd) in Chronic Lymphocytic Leukemia
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 9, 2025
Completion date
September 15, 2039
Enrollment
60 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

btk degraders, chronic lymphocytic leukemia